Revenue (Tables)

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Net Revenue by Organ and Country

The Company disaggregates revenue from contracts with customers related to OCS transplant by organ type and geographical area as it believes this presentation best depicts how the nature, amount, timing and uncertainty of the Company’s revenue and cash flows are affected by economic factors, as shown below (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
OCS transplant revenue by country   by organ(1)(2):
United States
Lung total revenue	$	4,243	$	2,817	$	8,949	$	4,248
Heart total revenue		27,173		13,456		47,397		26,412
Liver total revenue		77,039		32,674		143,965		55,788
Total United States OCS   transplant revenue		108,455		48,947		200,311		86,448
All other countries
Lung revenue		448		403		1,408		654
Heart revenue		4,268		3,108		7,399		6,910
Liver revenue		—		7		—		7
Total all other countries OCS   transplant revenue		4,716		3,518		8,807		7,571
Total OCS transplant revenue	$	113,171	$	52,465	$	209,118	$	94,019

(1)Revenue by country is categorized based on the location of the end customer. Total revenue includes product and service revenue.

(2)Service revenue unrelated to OCS transplant, which was $1.1 million and $2.0 for the three and six months ended June 30, 2024, respectively, and none for the three and six months ended June 30, 2023, is not included in this table.